STARPHARMA HOLDINGS LIMITED — Director's Dealing 2012

Feb 28, 2012

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	Starpharma Holdings Ltd
ABN 20 078 532 180

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Dr Jacinth K Fairley
Date of last notice	19 December 2011

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to therelevant interest.
Date of change	(i)22-23 February 2012(ii)24 February 2012(iii)27 February 2012(iv)27 February 2012
No. of securities held prior to change	1.1,769,197 Ordinary Shares (direct)2.53,750 Ordinary Shares (indirect) Dr IanFraser 3.375,000 Performance Rights (SPLAK)
Class	Ordinary Shares
Number acquired	Nil
Number disposed	(i)107,463(ii)18,787(iii)23,750(iv)23,750Total:173,750

+ See chapter 19 for defined terms.

Value/Consideration	(i)$153,906 ($1.43 per share)
Note: If consideration is non-cash, provide details and estimatedvaluation	(ii)$26,026 ($1.38 per share)
	(iii)$33,725 ($1.42 per share)
	(iv)$33,562 ($1.41 per share)
	Total:$247,219
No. of securities held after change	1.1,619,197 Ordinary Shares (direct)
	2.30,000 Ordinary Shares (indirect) Dr Ian
	Fraser
	3.375,000 Performance Rights (SPLAK)
	On-market sale of shares to partially fund the tax
Nature of change	liability associated with securities granted under
Example: on-market trade, off-market trade, exercise of options,issue of securities under dividend reinvestment plan, participationin buy-back	the Company's equity incentive plans.

Part 2 – Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract
Nature of interest
Name of registered holder(if issued securities)
Date of change
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changed
Interest acquired
Interest disposed
Value/ConsiderationNote: If consideration is non-cash, provide detailsand an estimated valuation
Interest after change

Part 3 – +Closed period

Were the interests in the securities or contracts detailed above	No
traded during a +closed period where prior written clearance was
required?
If so, was prior written clearance provided to allow the trade toproceed during this period?	N/A
If prior written clearance was provided, on what date was thisprovided?	N/A

+ See chapter 19 for defined terms.